GGrantIndex
← Leaderboards

Zachary Alan Klase

University Of The Sciences Philadelphia

$4,576,746
Attributed
$6,907,136
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY201525
$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,907,136 · 6

By mechanism

R01$2,741,871 · 1
DP2$2,137,500 · 1
R61$908,940 · 1
R21$835,250 · 2
R03$283,575 · 1

Others in their field

Top investigators on “Pharmaceutical Preparations

Research focus

Pharmaceutical PreparationsCellsInfectionMacrophageNeuroaidsViralGenetic TranscriptionMicrogliaCell TypeNeuropathogenesisNeuroinflammationAntiretroviral TherapyBrainAffectCentral Nervous SystemPublishingVirusEpigenetic ProcessPersonsHiv InfectionsImageMediatingSubstance Use DisorderVirus Replication

Grant awards (13)

Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2025 · DA
Examination of epigenetic spatial architecture in the CNS as a method to understand cocaine relapse in ecoHIV infected mice$454,470
R61 · FY2025 · DA · contact PI
Transcriptional silencing of HIV by LTR targeting RNAi$418,625
R21 · FY2025 · DA · contact PI
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2024 · DA
Examination of epigenetic spatial architecture in the CNS as a method to understand cocaine relapse in ecoHIV infected mice$454,470
R61 · FY2024 · DA · contact PI
Adult human brain tissue cultures to study neuroHIV$189,375
R21 · FY2024 · DA
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2023 · DA
Adult human brain tissue cultures to study neuroHIV$227,250
R21 · FY2023 · DA
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$695,124
R01 · FY2022 · DA
Understanding the overlap of chromatin alteration in HIV-1 and drug abuse$1,274,854
DP2 · FY2017 · DA · contact PI
Understanding the overlap of chromatin alteration in HIV-1 and drug abuse$862,646
DP2 · FY2017 · DA · contact PI
HIV-1 Tat inhibition of RNAi: Implications for NeuroAIDS and Substance Abuse$141,075
R03 · FY2016 · DA · contact PI
HIV-1 Tat inhibition of RNAi: Implications for NeuroAIDS and Substance Abuse$142,500
R03 · FY2015 · DA · contact PI